Skip to main content
Michael Konstan, MD, Pediatric Pulmonology, Cleveland, OH, University Hospitals Cleveland Medical Center

MichaelWKonstanMD

Pediatric Pulmonology Cleveland, OH

Professor of Pediatrics, Case West Res Univ

Dr. Konstan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Konstan's full profile

Already have an account?

  • Office

    UH Rainbow Babies and Children's Hospital
    11100 Euclid Ave Department of Pediatrics-Pulmonary
    Cleveland, OH 44106
    Phone+1 216-844-1750
    Fax+1 216-844-7960
  • Is this information wrong?

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1985 - 1988
  • University at Buffalo
    University at BuffaloResidency, Pediatrics, 1982 - 1985
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1982

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1982 - 2024
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Pulmonology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2004-2014
  • Northern Ohio Live Castle Connolly, 2006-2009

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Opportunities for Life Course Research Through the Integration of Data Across Clinical and Translational Research Institutes  
    Michael W Konstan, Shari L Barkin, James E Heubi, Journal of Clinical and Translational Science

Press Mentions

  • First Wave BioPharma Announces Phase 2 Adrulipase Combination Trial Data to Be Presented at the 2023 Digestive Disease Week (DDW) Conference
    First Wave BioPharma Announces Phase 2 Adrulipase Combination Trial Data to Be Presented at the 2023 Digestive Disease Week (DDW) ConferenceFebruary 21st, 2023
  • #NACFC2022 – LAU-7b May Prevent Lung Function Decline in CF
    #NACFC2022 – LAU-7b May Prevent Lung Function Decline in CFNovember 9th, 2022
  • AzurRx BioPharma Announces Formation of Scientific Advisory Board
    AzurRx BioPharma Announces Formation of Scientific Advisory BoardOctober 21st, 2020
  • Join now to see all

Grant Support

  • Research Career Development In Child HealthEunice Kennedy Shriver National Institute Of Child Health &Human Development2011–2012
  • Clinical StudiesNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
  • PTC124 As An Oral Treatment For Nonsense-Mutation-Mediated Cystic FibrosisNational Center For Research Resources2006
  • Tobramycin For Inhalation (TOBI) In Young Children With Cystic FibrosisNational Center For Research Resources2005
  • Oral Theraclec-Total In CF Patients With Exocrine Pancreatic InsufficiencyNational Center For Research Resources2005
  • Biil284bs In Adult And Pediatric Cystic Fibrosis PatientsNational Center For Research Resources2004–2005
  • Oral Theraclec-Total In Adult And Pediatric Subjects With Cystic FibrosisNational Center For Research Resources2004
  • Neutrophil Imaging Of The Lung For Characterizing Pulmonary Infection In CF PTSNational Center For Research Resources2004
  • Fat And Protein Absorption In Cystic Fibrosis PTS With Pancreatic InsufficiencyNational Center For Research Resources2004
  • Lower Airway Deposit Of Inhaled Tobramycin In Cystic FibNational Center For Research Resources2000–2002
  • Ins365 In Adult &Pediatric Cystic FibrosisNational Center For Research Resources2000–2002
  • Ib367 In Adult Patients With Cystic FibrosisNational Center For Research Resources2000–2002
  • Free Elastase Concentration In BAL Fluid In Cystic FibrosisNational Center For Research Resources2000–2002
  • Lung Specific Bioefficacy Of Oral DMP 777 In Adults W/ CFNational Center For Research Resources1999–2002
  • CPX (Oral, Multidose) In Adults W/ Mild To Moderately Severe Cystic FNational Center For Research Resources1999–2002
  • Dmp777 In Adult Patients 18 Yrs Of Age And Older With Cystic FibrosisNational Center For Research Resources1998–2000
  • CPX In Adult Patients With Mild Cystic FibrosisNational Center For Research Resources1998–2000
  • Prolastin Aerosol Therapy In Patients With Cystic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1996–2000
  • In Vivo Studies Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1994–2000
  • Trial In Patients With Mild Cystic Fibrosis To Determine Efficacy Of PulmozymeNational Center For Research Resources1996–1997
  • Bronchoalveolar Lavage Studies In Cystic FibrosisNational Center For Research Resources1996–1997
  • Inhalation Administration Of Alpha1-Pl By Aerosol In Cystic FibrosisNational Center For Research Resources1996
  • In Vivo Studies Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1992–1996
  • Pharmacokinetics Of Tobramycin Administered By Different Nebulizers To CF PTSNational Center For Research Resources1995
  • Pilot Study--Antiproteases And The Treatment Of Inflammation Of The Lung In CFNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1995
  • Intravenous ICI 200,880 In Stable Cystic Fibrosis OutpatientsNational Center For Research Resources1994
  • Clinical Trial Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1994
  • Secretory Leukocyte Protease Inhibitor Augmentation Therapy In CF PatientsNational Center For Research Resources1993
  • Intravenous Elastase Inhibitor In Stable Cyctic Fibrosis OutpatientsNational Center For Research Resources1993
  • Intravenous ICI 200,880 In Stable Cystic Fibrosis OutpatientsNational Center For Research Resources1992–1993
  • Clinical Trial Of Ibuprofen In Patients With Cystic FibrosisNational Center For Research Resources1990–1993
  • Pilot Study-- Antiproteases And The Treatment Of Inflammation Of The Lung In CFNational Institute Of Diabetes And Digestive And Kidney Diseases1991

Hospital Affiliations